MedGenome, a genomics-driven research and diagnostics company, announced it has raised $55 million in a new round of funding, led by global impact investment firm LeapFrog Investments. According to the Company’s statement: “The company’s two existing backers, Sequoia Capital and Belgian investor Sofina, have also participated in the latest round of equity financing.” The funds…